In recent years, the demand for Ultra-Low Temperature (ULT) freezers and refrigerators has witnessed a substantial uptick, driven by the increasing necessity to store a diverse range of temperature-sensitive biological materials. Enzymes, cell preparations, viruses, bacteria, drugs, chemicals, and tissue samples are among the many valuable substances that researchers and laboratories aim to preserve at ultra-low temperatures. This growing demand is closely tied to the expanding research and development activities in the biomedical industry, where precise storage conditions are paramount to maintaining the integrity and functionality of critical biological materials. The surge in demand for ULT freezers and refrigerators is underpinned by the indispensable role they play in preserving temperature-sensitive substances crucial for various research activities. Enzymes, for example, are molecular catalysts that drive biochemical reactions, and the stability of these biological molecules is paramount for their efficacy. Similarly, chemicals utilized in research must be stored under optimal conditions to ensure their integrity and suitability for experimentation. Viruses and bacteria, often subjects of intensive study in virology and microbiology, require stringent storage conditions to maintain their viability for ongoing research. ULT freezers provide an ideal environment for long-term storage, allowing researchers to access these biological materials when needed without compromising their quality. The pharmaceutical industry, a significant player in the biomedical landscape, has contributed substantially to the increasing demand for ULT freezers and refrigerators. The development and testing of new drugs entail the storage of various biological samples, including drugs themselves, at ultra-low temperatures to preserve their stability and effectiveness. This is crucial in drug discovery and clinical testing processes, where maintaining the properties of drugs is imperative for accurate research outcomes. Tissue samples, another critical component in biomedical research, require specialized storage to retain their structural and biochemical properties. ULT freezers play a pivotal role in the preservation of tissue samples, ensuring their availability for histological studies, genetic research, and other diagnostic purposes. The biomedical industry's emphasis on research and development has been a driving force behind the increased demand for ULT freezers. As scientific exploration delves deeper into understanding the intricacies of life at the molecular level, the need for precise and reliable storage solutions becomes even more pronounced. ULT freezers provide the controlled and ultra-low temperature environments required to safeguard the integrity of biological materials, enabling researchers to conduct experiments with confidence. Moreover, the growth of ULT freezers in the biomedical industry aligns with broader trends in research and technology. Advancements in genomics, proteomics, and personalized medicine necessitate sophisticated storage solutions for biological samples. The versatility of ULT freezers, capable of accommodating a wide range of materials, positions them as essential tools in the evolving landscape of biomedical research. In conclusion, the escalating demand for ULT freezers and refrigerators is a testament to their crucial role in preserving temperature-sensitive biological materials essential for biomedical research. From enzymes and chemicals to viruses, bacteria, drugs, and tissue samples, these bio-coolers are indispensable in maintaining the integrity and functionality of critical research materials. As the biomedical industry continues to advance, the reliance on ULT freezers is expected to grow, further emphasizing their significance in supporting groundbreaking research and development activities.
Report Attribute/Metric | Details |
---|---|
Segment Outlook | Type, Degree of cooling, Application, End-User, and Region |
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Market CAGR for ultra-low temperature freezers is driven by the growing demand for blood and blood products. Many of the body's most important processes require blood or blood components. Treating acute and chronic diseases caused by deficiencies or defects in plasma proteins or cellular blood components, including preventing complications like life-threatening hemorrhage and alleviating anemia-related symptoms, all rely on blood transfusions as a supportive therapy. The need for a blood transfusion might arise in either an urban or rural setting. As a result of inadequate procedures for storing and testing blood, millions of individuals are at risk of infection. The blood and blood components stored in the laboratory's freezers save lives because they are kept cold and protected from contamination. Market growth is partly fueled by increasing government initiatives to increase blood collection, efficient use, and individual awareness.
Additionally, greater investment in life sciences and life science is predicted to increase as more people use customized medicines, increasing demand for these freezers. A similar aspect that will boost investments in life science research is the rising need for medicines storage equipment at blood banks, academic & research facilities, and hospitals. Researchers in the field of life sciences would also benefit from the public's increasing awareness of opportunities to donate blood and organs. This element is therefore anticipated to contribute significantly to the expansion of the ultra-low temperature freezers market.
For instance, Pharmaceutical refrigerators with freezers (MPR-N250FH/N250FSH) and sliding-door pharmaceutical refrigerators (MPR-S500H/S500RH) were introduced by PHC Corporation. These inverter-compressor-equipped, natural-refrigerant-using machines were developed with the unique needs of laboratories and hospitals in mind. As a result, the demand for ultra-low temperature freezers is anticipated to increase throughout the projection period due to the rising blood demand. Thus, the driving factor is the ultra-low temperature freezers market revenue.
The market segments of ultra-low temperature freezers, based on type, includes upright and chest. In 2022, the upright segment led the market revenue for ultra-low temperature due to the reduced carbon footprint and the convenience of collecting samples from these locations. These freezers have minimal energy usage, low noise levels, and a smaller carbon footprint, in addition to their huge storage capacities.
Figure 1 Ultra-Low Temperature Freezers Market by Type, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
The ultra-low temperature freezers market segmentation, based on the degree of cooling, includes -41°C to -86°C Freezers and -87°C to -150°C Freezers. The -41°C to -86°C segment is expected to develop at a CAGR of 4.20% over the projected period, making up the largest market share due to Biological samples, tissues, blood and blood products, plant tissues, proteins, and DNA are typically stored in freezers between -41°C and -86°C for extended periods laboratories.
The market segmentation of ultra-low temperature freezers, based on application, includes blood & blood products, biological samples, and drug compounds. The drug compounds segment is expected to grow fastest at a CAGR of 7.53% in the coming years due to increases in spending on research and development for novel treatments, including biological, peptides, and molecular entities are expected to propel the drug compounds market over the next years.
Thermo Fisher Scientific (US) - June 2024: Thermo Fisher Scientific launched a new line of ULT freezers featuring advanced vacuum insulation panel (VIP) technology. This technology significantly improves energy efficiency and storage capacity while maintaining ultra-low temperatures. The new series also integrates smart monitoring systems for real-time temperature tracking and alerts, enhancing sample safety and compliance with regulatory standards.
Stirling Ultracold (Greece) - May 2024: Stirling Ultracold introduced an innovative ULT freezer that utilizes a Stirling engine cooling system. This new model is designed to offer unparalleled energy efficiency and reduced carbon footprint, aligning with global sustainability goals. The freezers are equipped with remote monitoring capabilities, allowing users to manage and monitor the units from anywhere, ensuring the integrity of stored biological samples and drug compounds.
Eppendorf AG (Germany) - April 2024: Eppendorf AG announced the development of a new ULT freezer model featuring adaptive temperature control technology. This advancement allows the freezer to adjust its cooling performance based on the load and ambient conditions, optimizing energy use and maintaining consistent temperatures. The model also includes user-friendly digital interfaces and enhanced data logging features for improved sample management and regulatory compliance.
The ultra-low temperature freezers market segmentation, based on end-user, includes drug compounds, hospitals & clinics, and academic & research laboratories. The segment with the largest market share in hospitals & clinics is expected to grow fastest at a CAGR of 4.20% over the next several years. Because Ultra-low temperature freezers are increasingly used to keep blood cells, plasma, and other biological substances at very low temperatures, demand for these goods will be bolstered by increased emergencies and accidents.
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American ultra-low temperature freezers market will dominate because there are so many established businesses in the area. In addition, new and local players are projected to make substantial investments in the sector of ultra-low temperature freezers, leading to the acquisition of major investments in freezing equipment to meet the growing demand for the preservation of various products.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 Ultra-Low Temperature Freezers Market Share By Region 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe’s ultra-low temperature freezers market accounts for the second-largest market share because there are so many hospitals and biobanks in the area. Further, the German market of ultra-low temperature freezers held the largest market share, and the UK market of ultra-low temperature freezers was the fastest-growing market in the European region.
The Asia-Pacific ultra-low temperature freezers market is expected to grow at the fastest CAGR from 2024 to 2032 due to the high volume of healthcare services and the consequent need for substantial archival and storage solutions. In addition, rising consumer demand for blood & blood products, and much research is being conducted on blood's subordinates. Moreover, China’s market of ultra-low temperature freezers held the largest market share, and the Indian market of ultra-low temperature freezers was the fastest-growing market in the Asia-Pacific region.
Ultra-Low Temperature Freezers Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the market of ultra-low temperature freezers grow even more. There are some strategies for action that market participants are implementing to increase their presence around the world's footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the ultra-low-temperature freezers industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics manufacturer use in the ultra-low temperature freezers industry to benefit clients and increase the market sector. In recent years, the ultra-low temperature freezers industry has offered some of the most significant technological advancements. Major players in the ultra-low temperature freezers market, including WR International LLC (US), Thermo Fisher Scientific (US), Eppendorf AG (Germany), Stirling Ultracold (Greece), PHC Corporation (US), Arctiko (UK), Helmer Scientific (US), BINDER GmbH (Germany), Labcold (UK), Esco Micro Pte Ltd (US), and others are attempting to increase market demand by investing in research and development operations.
Eppendorf is an industry-leading life sciences firm that designs, manufactures, and distributes laboratory equipment worldwide. Liquid Handling, Consumables, Separation & Instrumentation, and Bioprocess & Workflow Solutions are the four main categories into which the product catalog is broken down. Eppendorf also provides an extensive selection of consumables of the highest quality. Products manufactured by Eppendorf can be found in various industries, including the pharmaceutical, biotech, chemical, and food sectors. Clinical and environmental analysis labs employ forensics and manufacturing plants for process analysis, production, and quality control. Eppendorf was founded in 1945, has its headquarters in Hamburg, Germany, and currently employs over 5,000 people worldwide. The company has 33 international branches and is distributed in every major market worldwide. In April 2023, Eppendorf, a pioneer in the life sciences industry, released Centrifuge 5427 R, the company's first microcentrifuge with hydrocarbon cooling. Customers now have access to a natural cooling agent with a GWP of practically zero in a refrigerated device, allowing for a wider range of molecular and cell biology applications.
BioLife Solutions' Stirling Ultracold division creates and sells ULT freezers that maintain temperatures from -86 degrees Celsius to -20 degrees Celsius while using minimal energy. We are the industry standard in cell and gene therapy bioproduction services and serve the broader biopharma industry. By providing solutions that preserve the health and functionality of biological source material and finished products during manufacture, storage, and distribution, we aim to promote fundamental and applied research and develop and disseminate novel therapeutics. In October 2022, CSafe and BioLife Solutions, Inc., the largest provider of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, will provide a combined service network to support cell and gene therapy ("CGT") products, with a focus on improved reliability, security, and quality.
Key Companies in the market of Ultra-Low Temperature Freezers include
Ultra-Low Temperature Freezers Industry Developments
February 2023: PHC Corporation of North America, the distributor of the PHCbi brand of cell preservation and growth products in the North American and Latin American markets, has announced the release of the PHCbi brand VIP ECO® SMART ultra-low temperature freezer series. The latest range of ultra-low temperature freezers from PHCbi represents a continuation of the company's commitment to innovation and reliability in the field.
March 2023: BioLife Solutions, Inc. has officially announced the availability of Ultraguard, the first -70°C phase change material (“PCM”) created specifically for ultra-low temperature (ULT) protection that is non-toxic, non-hazardous, and non-flammable.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)